9 completed. 9 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 9 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow halofantrine: new trials by email Literature Review of halofantrine trials Research Report on halofantrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) Herpes zoster vaccination (Shingrix, GSK), Influenza Vaccine (Fluarix Tetra Northern Hemisphere 2021 or 2022, GSK), Placebo - Influenza, Herpes Zoster | Phase 2 | Completed | Radboud University Medical Center | 148 | 2021-09-20 | 2023-06-29 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A), Nimenrix powder and solvent for solution for injection in pre-filled syringe; Meningococcal group A, C, W-135 and Y conjugate vaccine - Virus Diseases | Phase 2 | Completed | GlaxoSmithKline | 600 | 2015-11-09 | 2018-05-03 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults GlaxoSmithKline (GSK) Biologicals' investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (ChAd3-EBO-Z) (GSK3390107A), Placebo - Virus Diseases | Phase 2 | Completed | GlaxoSmithKline | 3024 | 2015-07-15 | 2018-01-04 |
| Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis Lapatinib - HER2-positive Gastric Cancer Patients With Liver Metastasis | Phase 2 | Completed | Samsung Medical Center | 32 | 2012-07-09 | 2018-01-17 |
| Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults Adjuvanted vaccine against H1N1 influenza virus (GSK) - HIV Infection | Phase 2 | Completed | Oswaldo Cruz Foundation | 450 | 2010-03-01 | 2018-07-18 |
| The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma LMWH, TACE - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Completed | Eastern Hepatobiliary Surgery Hospital | 100 | 2008-12-01 | 2016-04-01 |
| Use of N-Acetylcysteine During Liver Procurement N-acetylcystein - Liver Failure, Liver Failure, Acute | Phase 2 | Completed | Azienda Ospedaliera di Padova | 140 | 2006-12-01 | 2013-02-18 |
| Use of Sodium Stibogluconate as a Treatment for Leishmaniasis Sodium Stibogluconate (SSG) - Leishmaniasis | Phase 1 / Phase 2 | Completed | U.S. Army Medical Research and Development Command | 77 | 2004-10-01 | 2020-01-02 |
| Sodium Stibogluconate Treatment of Leishmaniasis Sodium Stibogluconate (SSG) - Leishmaniasis | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 414 | 2002-06-01 | 2021-02-12 |
Carcinoma, Hepatocellular (2) · Leishmaniasis (2) · Liver Diseases (2) · Liver Neoplasms (2) · Virus Diseases (2) · Adenocarcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Neoplasms (1) · HIV Infections (1) · Herpes Zoster (1) · Influenza, Human (1) · Liver Failure (1) · Liver Failure, Acute (1) · Neoplasms (1)
GlaxoSmithKline (2) · U.S. Army Medical Research and Development Command (2) · Azienda Ospedaliera di Padova (1) · Eastern Hepatobiliary Surgery Hospital (1) · Oswaldo Cruz Foundation (1) · Radboud University Medical Center (1) · Samsung Medical Center (1)
Mali (2) · Senegal (2) · United States (2) · Brazil (1) · Cameroon (1) · China (1) · Italy (1) · Netherlands (1) · Nigeria (1) · South Korea (1)
Francesco D'Amico, MD (1) · Glenn Wortmann, MD (1) · Jeeyun Lee, MD, PhD (1) · Roseanne Ressner, MD (1) · Shen Feng, MD (1) · Umberto Cillo, MD (1)
PMID 22761759, PMID 22859317, PMID 32199491, PMID 32199492
2014 (1)